Use of Left Ventricular Support Devices During Acute Coronary Syndrome and Percutaneous Coronary Intervention

Spiro, J.; Doshi, Sagar N.

doi:10.1007/s11886-014-0544-x

Cited by 10 publications

(11 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mortality and complications were low, and despite the highly complex and mostly extensive coronary artery disease of these patients PCI was successful in all cases. PCI under ECMO in unstable patients with STelevation myocardial infarction and/or cardiogenic shock has been reported to be relatively safe with a good outcome [9,13]. Literature about high-risk PCI under ECMO support in stable patients, however, is scarce to date.…”

Section: Discussionmentioning

confidence: 99%

“…In the past, high-risk PCI could be performed under mechanical circulatory support using the intraaortic balloon pump (IABP), but its use has seen a decline and downgrade in this regard as studies have failed to display a clear benefit of this form of mechanical circulatory support [6][7][8]. Recently, high-risk PCI under mechanical support, especially extracorporeal membrane oxygenation (ECMO) and the Impella device (Abiomed, Aachen, Germany), has been established as a possible alternative for this group of highrisk patients [9][10][11][12]. Initial reports on the use of venoarterial (VA)-ECMO showed promising results in the treatment of cardiogenic shock due to myocardial infarction [13][14][15].…”

Section: Introductionmentioning

confidence: 99%

“…Patients with stable coronary artery disease have also been revascularised with mechanical support using VA-ECMO. However, data on outcome and procedural characteristics are scarce [9,10].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Prophylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention

Brink

Meijers²,

Hofma

et al. 2019

Neth Heart J

View full text Add to dashboard Cite

Purpose Complex high-risk percutaneous coronary intervention (PCI) is challenging and frequently accompanied by haemodynamic instability. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) can provide cardiopulmonary support in highrisk PCI. However, the outcome is unclear. Methods A two-centre, retrospective study was performed of all patients undergoing high-risk PCI and receiving VA-ECMO for cardiopulmonary support. Results A total of 14 patients (92% male, median age 69 (53-83) years), of whom 50% had previous coronary artery disease in the form of a coronary artery bypass graft (36%) and a PCI (14%) underwent highrisk PCI and received VA-ECMO support. The main target lesion was a left main coronary artery in 78%, a left anterior descending artery in 14%, a right coronary artery in 7%, and 71% underwent multi-vessel PCI in addition to main target vessel PCI. The median SYNTAX score was 27.2 (8-42.5) and in 64% (9/14) there was a chronic total occlusion. Left ventricular function was mildly impaired in 7% (1/14), moderately impaired in 14% (2/14) and severely impaired in F. S. van den Brink () • S.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prophylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention

Brink

Meijers²,

Hofma

et al. 2019

Neth Heart J

View full text Add to dashboard Cite

show abstract

“…IABP using could alleviate the burden of the left ventricle and improve cardiac function through reducing left ventricular ejection resistance. Studies have shown that IABP enhanced the pulsation of coronary arteries and provided pulsed blood flow, which were beneficial to reduce the occurrence of acute occlusion and no reflow after PCI treatment 18 .…”

Section: Discussionmentioning

confidence: 99%

Effects of Duration of Using Intraaortic Balloon Pump on Renal Function and Clinical Outcome

Chen¹,

Xiao-fan²,

Ma³

2021

Preprint

View full text Add to dashboard Cite

Objective:To integrate the effects of duration of using intraaortic balloon pump (IABP) on renal function, major adverse cardiac events (MACEs) and all-cause mortality in patients with acute myocardial infarction (AMI) complicating pump failure. Methods:Between March 2017 and June 2018, a retrospective study enrolled 306 patients with AMI complicating pump failure who underwent coronary artery angiography (CAG) or percutaneous coronary intervention (PCI) was conducted. Patients were divided into the duration ≤4 days and the duration＞4 days in basis of median the IABP duration. We compared the renal function parameters at the three time section of IABP implantation between two groups. Analysis of factors of contrast-induced nephropathy (CIN), 12-month MACEs and all-cause mortality were also performed. Results:There were 146 patients in IABP duration ≤4 days and 92 patients in IABP duration > 4 days. Renal function was only correlated with IABP duration instead of timing of IABP implantation. On multivariate analysis, CIN risk increased by 81.2% (RR= 1.812, 95%CI, 1.167–3.763) for every 100mL increment of contrast agent. Hematocrit, blood platelet, IABP use >4 days were significantly inversely associated with CIN. Cox-regression analysis suggested that IABP duration was not significantly correlated with the incidence of 12-month MACEs and all-cause mortality. Conclusion:Longer duration of IABP implantation was beneficial to renal function, but was not significantly correlated with the incidence of 12-month MACEs and all-cause mortality in patients with AMI complicating pump failure. Patients undergoing PCI or CABG should notice that the potential damage of high dose of contrast agents on the renal function.

show abstract

“…Different new devices have been proposed as adjunctive treatment in order to sustain cardiac output until the recovery of ventricular function following revascularisation or as a bridge to surgical bypass [20].…”

Section: Use Of New Devices For Mechanical Circulatory Supportmentioning

confidence: 99%

Current Concepts and New Trends in the Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction

Benedek

Dobreanu

2015

The Journal of Critical Care Medicine

View full text Add to dashboard Cite

Cardiogenic shock (CS) is a critical condition which often complicates the evolution of an acute myocardial infarction (AMI). At the same time, co-existence of chronic multi-vessel disease can lead to the development of cardiogenic shock in cases with pronounced haemodynamic instability. Different clinical studies have tried to identify the most appropriate treatment for critical cases of CS complicating AMI. This review aims to present the current status of recommended therapeutic strategies for severe cases of CS presenting as a complication of AMI, and try to shed light on the most appropriate therapeutic strategy as outlined in the current literature. The paper will discuss the different current strategies available for use in the treatment of this condition, includig interventional revascularisation, (complete or culprit), the role of new devices for providing mechanical circulatory support, and the potential role of new drug therapies and of hypothermia.

show abstract

Use of Left Ventricular Support Devices During Acute Coronary Syndrome and Percutaneous Coronary Intervention

Cited by 10 publications

References 55 publications

Prophylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention

Prophylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention

Effects of Duration of Using Intraaortic Balloon Pump on Renal Function and Clinical Outcome

Current Concepts and New Trends in the Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction

Contact Info

Product

Resources

About